Overview

Many myeloproliferative neoplasms (MPNs) share similar symptoms, but it is important to distinguish, diagnose, and treat MPNs appropriately. An expert faculty will share strategies for identifying MPNs and their associated recommended management. Participants will gain a better understanding of novel therapies and evidence-based treatment plans for those diagnosed with MPN by walking through realistic clinical scenarios during this activity.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Review the clinical features of myeloproliferative neoplasms with a focus on chronic myeloid leukemia, chronic eosinophilic leukemia, and primary myelofibrosis
2. Identify novel management approaches for the myeloproliferative neoplasms discussed integrating genetics, patient-specific factors, and new therapies
3. Describe evidence-based treatment plans for patients diagnosed with myeloproliferative neoplasms using clinical scenarios